Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if LiRIS®, an investigational drug-delivery system,
is safe, tolerable and effective in women with Interstitial Cystitis. LiRIS® is inserted into
the bladder via cystoscopy , remains in the bladder for 14 days, and is removed via
cystoscopy.